Vigmed increases deficit and sales operations
Swedish-based medtech group Vigmed ermerges from 2014 with a sizeable deficit. But the company has reinforced its commercial activities and is now better positioned to take on more markets.
BY ANTON GRÆSDAL MAAJEN
Sales of products have taken off, but not nearly enough to secure a profit.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Vigmed opens subsidiary and changes market
For abonnenter
